Overview
Evidence-based recommendations on the SepsiTest assay for rapidly identifying bloodstream bacteria and fungi.
In February 2020, we removed the LightCycler SeptiFast Test MGRADE assay and the IRIDICA BAC BSI assay from the recommendation in this guidance because they are no longer available to the NHS. Updated information is denoted as [2020].
Diagnostics guidance 20 has been migrated to HealthTech guidance 400.
Last reviewed: 19 February 2020
We reviewed the evidence and found nothing new that affects the recommendations in this guidance. See the review decision for more details.
Next review: This guidance will be reviewed if there is new evidence that is likely to affect the recommendations.
Guidance development process
How we develop diagnostics guidance
This diagnostics guidance was previously called Tests for rapidly identifying bloodstream bacteria and fungi (LightCycler SeptiFast Test MGRADE, SepsiTest and IRIDICA BAC BSI assay)